The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons

Author:

Kamarajah Sivesh K1ORCID,Markar Sheraz R23ORCID,Singh Pritam4,Griffiths Ewen A5,

Affiliation:

1. Northern Oesophagogastric Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK

2. Department of Upper Gastrointestinal Surgery, St. Mary’s Campus, Imperial College London, London, UK

3. Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden

4. Department of Upper Gastrointestinal Surgery, Royal Surrey County Hospital, London, UK

5. Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital, Birmingham, UK

Abstract

Abstract Background Several guidelines to guide clinical practice among esophagogastric surgeons during the COVID-19 pandemic were produced. However, none provide reflection of current service provision. This international survey aimed to clarify the changes observed in esophageal and gastric cancer management and surgery during the COVID-19 pandemic. Methods An online survey covering key areas for esophagogastric cancer services, including staging investigations and oncological and surgical therapy before and during (at two separate time-points—24th March 2020 and 18th April 2020) the COVID-19 pandemic were developed. Results A total of 234 respondents from 225 centers and 49 countries spanning six continents completed the first round of the online survey, of which 79% (n = 184) completed round 2. There was variation in the availability of staging investigations ranging from 26.5% for endoscopic ultrasound to 62.8% for spiral computed tomography scan. Definitive chemoradiotherapy was offered in 14.8% (adenocarcinoma) and 47.0% (squamous cell carcinoma) of respondents and significantly increased by almost three-fold and two-fold, respectively, in both round 1 and 2. There were uncertainty and heterogeneity surrounding prioritization of patients undergoing cancer resections. Of the surgeons symptomatic with COVID-19, only 40.2% (33/82) had routine access to COVID-19 polymerase chain reaction testing for staff. Of those who had testing available (n = 33), only 12.1% (4/33) had tested positive. Conclusions These data highlight management challenges and several practice variations in caring for patients with esophagogastric cancers. Therefore, there is a need for clear consistent guidelines to be in place in the event of a further pandemic to ensure a standardized level of oncological care for patients with esophagogastric cancers.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Reference34 articles.

1. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response;Grasselli;JAMA,2020

2. Global survey on pancreatic surgery during the COVID-19 pandemic;Oba;Ann Surg,2020

3. How COVID-19 outbreak is impacting colorectal cancer patients in Italy: a long shadow beyond infection;Pellino;Dis Colon Rectum,2020

4. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang;Lancet Oncol,2020

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3